Pharmacoepidemiology and Drug Safety

Cover image for Pharmacoepidemiology and Drug Safety

September 2002

Volume 11, Issue 6

Pages 437–544

  1. Editorials

    1. Top of page
    2. Editorials
    3. Original Reports
    4. Editorials
    5. Original Reports
    6. ISPE Commentaries
    7. Current Awareness
    1. A drug is not a drug is not a drug: a commentary (pages 437–438)

      H. A. J. Struijker Boudier

      Version of Record online: 26 SEP 2002 | DOI: 10.1002/pds.767

  2. Original Reports

    1. Top of page
    2. Editorials
    3. Original Reports
    4. Editorials
    5. Original Reports
    6. ISPE Commentaries
    7. Current Awareness
    1. Postmarketing drug dosage changes of 499 FDA-approved new molecular entities, 1980–1999 (pages 439–446)

      James Cross, Howard Lee, Agnes Westelinck, Julie Nelson, Charles Grudzinskas and Carl Peck

      Version of Record online: 12 AUG 2002 | DOI: 10.1002/pds.744

    2. Changes in prescribed drug doses after market introduction (pages 447–453)

      Eibert R. Heerdink, John Urquhart and Hubert G. Leufkens

      Version of Record online: 12 AUG 2002 | DOI: 10.1002/pds.745

  3. Editorials

    1. Top of page
    2. Editorials
    3. Original Reports
    4. Editorials
    5. Original Reports
    6. ISPE Commentaries
    7. Current Awareness
    1. Ayurvedic medicines (pages 455–456)

      E. Ernst

      Version of Record online: 26 SEP 2002 | DOI: 10.1002/pds.756

  4. Original Reports

    1. Top of page
    2. Editorials
    3. Original Reports
    4. Editorials
    5. Original Reports
    6. ISPE Commentaries
    7. Current Awareness
    1. Calcium channel blockers and myocardial infarction: a case–control study in a Japanese hospital (pages 487–492)

      Yoshiharu Ohyama, Kazuhiro Funao, Eri Kawabe, Doubun Hayashi, Tsutomu Yamazaki, Tatsuji Iga, Daisuke Koide, Kazuhiko Ohe and Kiyoshi Kubota

      Version of Record online: 19 AUG 2002 | DOI: 10.1002/pds.743

    2. Use of calcium channel blockers as antihypertensives in relation to mortality and cancer incidence: a population-based observational study (pages 493–497)

      Gunnar Lindberg, Ulf Lindblad, Bent Löw-Larsen, Juan Merlo, Arne Melander and Lennart Råstam

      Version of Record online: 19 AUG 2002 | DOI: 10.1002/pds.737

    3. Variations in antidepressant prescribing practice: clinical need or market influences? (pages 515–522)

      Carlos De Las Cuevas, Emilio J. Sanz and Juan A. De La Fuente

      Version of Record online: 19 AUG 2002 | DOI: 10.1002/pds.715

  5. ISPE Commentaries

    1. Top of page
    2. Editorials
    3. Original Reports
    4. Editorials
    5. Original Reports
    6. ISPE Commentaries
    7. Current Awareness
    1. Introducing ethics in hospital drug resource allocation decisions: keep expectations modest and beware of unintended effects Part I: An explorative overview (pages 523–527)

      Roel Fijn, L. Sara van Epenhuysen, A. Jeanne M. Peijnenburg, Lolkje T. W. de Jong-van den Berg and Jacobus R. B. J. Brouwers

      Version of Record online: 26 SEP 2002 | DOI: 10.1002/pds.751

  6. Current Awareness

    1. Top of page
    2. Editorials
    3. Original Reports
    4. Editorials
    5. Original Reports
    6. ISPE Commentaries
    7. Current Awareness

SEARCH

SEARCH BY CITATION